TCM
HZNP

Tributary Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Tributary Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,645
Closed -$422K – 165
2023
Q3 		$422K Sell
3,645
-50
-1% -$5.37K 0.04% 133
2023
Q2 		$380K Sell
3,695
-100
-3% -$10.6K 0.03% 153
2023
Q1 		$414K Sell
3,795
-4,930
-57% -$545K 0.04% 143
2022
Q4 		$993K Sell
8,725
-125
-1% -$10.4K 0.1% 73
2022
Q3 		$548K Buy
8,850
+1,200
+16% +$83.8K 0.06% 104
2022
Q2 		$610K Sell
7,650
-18,350
-71% -$1.74M 0.06% 93
2022
Q1 		$2.73M Sell
26,000
-1,500
-5% -$146K 0.22% 71
2021
Q4 		$2.96M Sell
27,500
-2,150
-7% -$235K 0.22% 72
2021
Q3 		$3.25M Sell
29,650
-7,150
-19% -$742K 0.25% 73
2021
Q2 		$3.45M Buy
36,800
+4,350
+13% +$400K 0.26% 66
2021
Q1 		$2.99M Hold
32,450
– – 0.23% 70
2020
Q4 		$2.37M Sell
32,450
-1,700
-5% -$126K 0.17% 88
2020
Q3 		$2.65M Buy
34,150
+25,750
+307% +$1.77M 0.23% 75
2020
Q2 		$467K Buy
+8,400
New +$359K 0.04% 178

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tributary Capital Management's HZNP Position: Q4 2023 in Review

Tributary Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,645 shares — an estimated $422K sold.

Tributary Capital Management first reported a position in HZNP in Q2 2020 and held it in 14 quarters. The position peaked at $3.45M in Q2 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Tributary Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Tributary Capital Management sold 3,645 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $422K.
  • Tributary Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 14 quarters.
  • Tributary Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.45M in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Tributary Capital Management's 13F filing for Q4 2023, filed 16 Jan 2024.